Skip to main content
Premium Trial:

Request an Annual Quote

Forsyth, Kuwaiti Organizations Collaborate on Type 2 Diabetes Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Forsyth Institute today announced a research collaboration with the Dasman Diabetes Institute of Kuwait directed at type 2 diabetes in children.

The five-year agreement will also explore conditions that predispose children to obesity and research will be directed at maintaining metabolic health in children, Forsyth said in a statement. The Kuwait Dental School is also participating in the alliance.

Forsyth added that Kuwaiti scientists will largely manage the clinical research.

Financial terms of the partnership were not disclosed.

Scientists at Forsyth, based in Cambridge, Mass., will focus on discovering biomarkers in saliva that may indicate metabolic disease and the development of diabetes. A spokesperson for Forsyth said that the biomarkers being explored are proteins, metabolites, and oral microbes.

The Forsyth team is being led by J. Max Goodson, who is developing diagnostic tools suitable for the large-scale investigation of disease conditions in children that lead to diabetes.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.